United States · 
Who invested in Pathalys Pharma?
Pathalys Pharma's investors include OrbiMed, TCG, Samsara BioCapital and TCG Crossover.
United States · Series B startup
Who invested in Pathalys Pharma
Funding summaryUpdated 26 Oct 2026
$105Mraised across 1 round since 2024, from 1 source
- Latest round
- Series B, $105MAug 2024
- Investors
- 4
The rounds
- Aug 2024
Founders and team
From Pathalys Pharma's own website: 2 on the team.
- Pam DanagherSVP Head of Regulatory Affairs
- Joseph SilettoBoard Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Pathalys Pharma
How much has Pathalys Pharma raised?
Pathalys Pharma has raised $105M across 1 round since 2024.
When did Pathalys Pharma last raise?
Pathalys Pharma's most recent round was a Series B of $105M in Aug 2024.
What was Pathalys Pharma's biggest round?
Its most recent round, $105M in Aug 2024, is also its largest on record.
Who backed Pathalys Pharma first?
Pathalys Pharma's first round on record, in Aug 2024, was backed by OrbiMed, TCG and Samsara BioCapital and 1 others.
What stage is Pathalys Pharma at?
Pathalys Pharma's latest named round is a Series B, in Aug 2024.
Where is Pathalys Pharma based?
Pathalys Pharma is based in the United States.
Companies like Pathalys Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.